Structural determination of estrogen-related receptor γ in the presence of phenol derivative compounds

Journal of Steroid Biochemistry and Molecular Biology

Volumn 108, Issue 1-2, 2008, Pages 44-54

  Abad, Marta C ^a   Askari, Hossein ^a   O'Neill, John ^a   Klinger, Alexandra L ^a   Milligan, Cynthia ^a   Lewandowski, Frank ^a   Springer, Barry ^a   Spurlino, John ^a   Rentzeperis, Dionisios ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

4 Chloro 3 methyl phenol; 4 Hydroxy tamoxifen; Bisphenol A; Estrogen related receptor

Indexed keywords

4 HYDROXYTAMOXIFEN; 4,4' ISOPROPYLIDENEDIPHENOL; CELL NUCLEUS RECEPTOR; CHLOROCRESOL; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR GAMMA; PEPTIDE FRAGMENT; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; LIGAND BINDING; PROTEIN CONFORMATION; STRUCTURE ANALYSIS; THERMODYNAMICS;

CRYSTALLOGRAPHY, X-RAY; HUMANS; LIGANDS; MODELS, MOLECULAR; PHENOLS; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; SUBSTRATE SPECIFICITY;

EID: 38649142406     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.06.006     Document Type: Article

References (50)

1. Olefsky J.M. Nuclear receptor minireview series. J. Biol. Chem. 276 40 (2001) 36863-36864
2. Chawla A., Repa J.J., Evans R.M., and Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 294 5548 (2001) 1866-1870
3. Kliewer S.A., Lehmann J.M., and Willson T.M. Orphan nuclear receptors: shifting endocrinology into reverse. Science 284 5415 (1999) 757-760
4. Glass C.K. Going nuclear in metabolic and cardiovascular disease. J. Clin. Invest. 116 3 (2006) 556-560
5. Smith A.G., and Muscat G.E. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int. J. Biochem. Cell Biol. 37 10 (2005) 2047-2063
6. Horard B., and Vanacker J.M. Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J. Mol. Endocrinol. 31 3 (2003) 349-357
7. Escriva H., Delaunay F., and Laudet V. Ligand binding and nuclear receptor evolution. BioEssays 22 8 (2000) 717-727
8. Aranda A., and Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81 3 (2001) 1269-1304
9. Moras D., and Gronemeyer H. The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10 3 (1998) 384-391
10. Kumar R., Johnson B.H., and Thompson E.B. Overview of the structural basis for transcription regulation by nuclear hormone receptors. Essays Biochem. 40 (2004) 27-39
11. Giguere V. Orphan nuclear receptors: from gene to function. Endocr. Rev. 20 5 (1999) 689-725
12. Blumberg B., and Evans R.M. Orphan nuclear receptors-new ligands and new possibilities. Genes Dev. 12 20 (1998) 3149-3155
13. Giguere V., Yang N., Segui P., and Evans R.M. Identification of a new class of steroid hormone receptors. Nature 331 6151 (1988) 91-94
14. Hong H., Yang L., and Stallcup M.R. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem. 274 32 (1999) 22618-22626
15. Kraus R.J., Ariazi E.A., Farrell M.L., and Mertz J.E. Estrogen-related receptor alpha 1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells. J. Biol. Chem. 277 27 (2002) 24826-24834
16. Johnston S.D., Liu X., Zuo F., Eisenbraun T.L., Wiley S.R., Kraus R.J., and Mertz J.E. Estrogen-related receptor alpha 1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements. Mol. Endocrinol. 11 3 (1997) 342-352
17. Vanacker J.M., Pettersson K., Gustafsson J.A., and Laudet V. Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ERbeta. EMBO J. 18 15 (1999) 4270-4279
18. Giguere V. To ERR in the estrogen pathway. Trends Endocrinol. Metab. 13 5 (2002) 220-225
19. Zhang Z., and Teng C.T. Estrogen receptor-related receptor alpha 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J. Biol. Chem. 275 27 (2000) 20837-20846
20. Ariazi E.A., Clark G.M., and Mertz J.E. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res. 62 22 (2002) 6510-6518
21. Coward P., Lee D., Hull M.V., and Lehmann J.M. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Proc. Natl. Acad. Sci. U.S.A. 98 15 (2001) 8880-8884
22. Heard D.J., Norby P.L., Holloway J., and Vissing H. Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol. Endocrinol. 14 3 (2000) 382-392
23. Sanyal S., Matthews J., Bouton D., Kim H.J., Choi H.S., Treuter E., and Gustafsson J.A. Deoxyribonucleic acid response element-dependent regulation of transcription by orphan nuclear receptor estrogen receptor-related receptor gamma. Mol. Endocrinol. 18 2 (2004) 312-325
24. Powelka A.M., Seth A., Virbasius J.V., Kiskinis E., Nicoloro S.M., Guilherme A., Tang X., Straubhaar J., Cherniack A.D., Parker M.G., and Czech M.P. Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes. J. Clin. Invest. 116 1 (2006) 125-136
25. Kamei Y., Ohizumi H., Fujitani Y., Nemoto T., Tanaka T., Takahashi N., Kawada T., Miyoshi M., Ezaki O., and Kakizuka A. PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl. Acad. Sci. U.S.A. 100 21 (2003) 12378-12383
26. Rosen J., Marschke K., and Rungta D. Nuclear hormone receptor assays for drug discovery. Curr. Opin. Drug Discov. Dev. 6 2 (2003) 224-230
27. Shiau A.K., Coward P., Schwarz M., and Lehmann J.M. Orphan nuclear receptors: from new ligand discovery technologies to novel signaling pathways. Curr. Opin. Drug Discov. Dev. 4 5 (2001) 575-590
28. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., and Thaller C. 9-cis-Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68 2 (1992) 397-406
29. Willy P.J., Murray I.R., Qian J., Busch B.B., Stevens Jr. W.C., Martin R., Mohan R., Zhou S., Ordentlich P., Wei P., Sapp D.W., Horlick R.A., Heyman R.A., and Schulman I.G. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand. Proc. Natl. Acad. Sci. U.S.A. 101 24 (2004) 8912-8917
30. Busch B.B., Stevens Jr. W.C., Martin R., Ordentlich P., Zhou S., Sapp D.W., Horlick R.A., and Mohan R. Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha. J. Med. Chem. 47 23 (2004) 5593-5596
31. Greschik H., Flaig R., Renaud J.P., and Moras D. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J. Biol. Chem. 279 32 (2004) 33639-33646
32. Zuercher W.J., Gaillard S., Orband-Miller L.A., Chao E.Y., Shearer B.G., Jones D.G., Miller A.B., Collins J.L., McDonnell D.P., and Willson T.M. Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRbeta and ERRgamma. J. Med. Chem. 48 9 (2005) 3107-3109
33. Pantoliano M.W., Petrella E.C., Kwasnoski J.D., Lobanov V.S., Myslik J., Graf E., Carver T., Asel E., Springer B.A., Lane P., and Salemme F.R. High-density miniaturized thermal shift assays as a general strategy for drug discovery. J. Biomol. Screen 6 6 (2001) 429-440
34. Rentzeperis D., Marky L.A., Dwyer T.J., Geierstanger B.H., Pelton J.G., and Wemmer D.E. Interaction of minor groove ligands to an AAATT/AATTT site: correlation of thermodynamic characterization and solution structure. Biochemistry 34 9 (1995) 2937-2945
35. Grasberger B.L., Lu T., Schubert C., Parks D.J., Carver T.E., Koblish H.K., Cummings M.D., LaFrance L.V., Milkiewicz K.L., Calvo R.R., Maguire D., Lattanze J., Franks C.F., Zhao S., Ramachandren K., Bylebyl G.R., Zhang M., Manthey C.L., Petrella E.C., Pantoliano M.W., Deckman I.C., Spurlino J.C., Maroney A.C., Tomczuk B.E., Molloy C.J., and Bone R.F. Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. J. Med. Chem. 48 4 (2005) 909-912
36. Matulis D., Kranz J.K., Salemme F.R., and Todd M.J. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry 44 13 (2005) 5258-5266
37. Greschik H., Wurtz J.M., Sanglier S., Bourguet W., van Dorsselaer A., Moras D., and Renaud J.P. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Mol. Cell 9 2 (2002) 303-313
38. Quesada I., Fuentes E., Viso-Leon M.C., Soria B., Ripoll C., and Nadal A. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. FASEB J. 16 12 (2002) 1671-1673
39. 2+ release. Mol. Pharmacol. 44 6 (1993) 1192-1201
40. Suetsugi M., Su L., Karlsberg K., Yuan Y.C., and Chen S. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol. Cancer Res. 1 13 (2003) 981-991
41. Himmel D.M., Gourinath S., Reshetnikova L., Shen Y., Szent-Gyorgyi A.G., and Cohen C. Crystallographic findings on the internally uncoupled and near-rigor states of myosin: further insights into the mechanics of the motor. Proc. Natl. Acad. Sci. U.S.A. 99 20 (2002) 12645-12650
42. Tanenbaum D.M., Wang Y., Williams S.P., and Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. U.S.A. 95 11 (1998) 5998-6003
43. Kallen J., Schlaeppi J.M., Bitsch F., Filipuzzi I., Schilb A., Riou V., Graham A., Strauss A., Geiser M., and Fournier B. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha. J. Biol. Chem. 279 47 (2004) 49330-49337
44. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., and Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 7 (1998) 927-937
45. Zhang Z., Chen K., Shih J.C., and Teng C.T. Estrogen-related receptors-stimulated monoamine oxidase B promoter activity is down-regulated by estrogen receptors. Mol. Endocrinol. 20 7 (2006) 1547-1561
46. Kojo H., Tajima K., Fukagawa M., Isogai T., and Nishimura S. A novel estrogen receptor-related protein gamma splice variant lacking a DNA binding domain exon modulates transcriptional activity of a moderate range of nuclear receptors. J. Steroid Biochem. Mol. Biol. (2006)
47. Barry J.B., and Giguere V. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha. Cancer Res. 65 14 (2005) 6120-6129
48. Barry J.B., Laganiere J., and Giguere V. A single nucleotide in an estrogen-related receptor alpha site can dictate mode of binding and peroxisome proliferator-activated receptor gamma coactivator 1alpha activation of target promoters. Mol. Endocrinol. 20 2 (2006) 302-310
49. Carson M. RIBBONS 2.0. J. Appl. Cryst. 24 (1991) 928-961
50. W.L. DeLano, The PyMOL molecular graphics system, 2002.